Sep 2026 · Intimation Regarding Dispatch Of Letter To Those Shareholders Whose E-Mail Address Are Not Registered For Annual Report Of FY 2025-2026 5 Sep - 36th AGM on 30 Sep 2026; board recommended Rs 1.50 dividend for FY26.
Source: Bse
Industrials stocks · Small cap · NSE
Asahi Songwon Colors Limited manufactures blue (Phthalocyanine) pigments for ink, plastics, paint, textile, and paper industries. It has diversified into yellow, red, orange (AZO) pigments, and APIs. The company operates 4 manufacturing facilities and exports to 19 countries, with 69% of its revenue from exports in FY26.
full bull SMA stack · SMA20 +2.4% / mo · MACD + · near 52W high
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, while price trend supports entry. This looks more like momentum/speculation than a clean fundamental investment setup.
Weak U-Score but strong trend: momentum may be ahead of fundamentals.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +26.0% · PAT +533.3% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +26% YoY · PAT +533% YoY · margin expansion · +31% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹189 Cr | +26.0% | +31.3% |
| EBITDA | ₹32 Cr | +190.9% | +60.0% |
| Operating margin | 17.0% | +1000 bps | +300 bps |
| PAT | ₹19 Cr | +533.3% | +72.7% |
| PAT margin | 10.1% | +805 bps | +241 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 18/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is constructive — long-term uptrend intact. RSI 54.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 38 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4FY26 saw strong revenue and profitability growth in phthalocyanine pigments, driven by stronger realizations. The API business faced high raw material costs and Chinese competition but experienced a reversal in its price erosion cycle. Both Azo and API businesses achieved full-year EBITDA positivity and cash break-even.
The company demonstrated resilience in Q4FY26, with strong performance in its core pigment business and operational improvements in newer API and Azo segments. While raw material volatility and competition persist, management's focus on efficiency, backward integration, and strategic certifications like CEP could drive future growth and profitability.
Latest issuer-disclosed distribution across 2 reported categories.
Joint venture with Tennants Textiles Colours Limited (TTC) for red, yellow, and orange Azo pigments. China accounts for >50% of global pigment production, and a production shift from China positions Asahi favorably.
Acquired remaining 22% stake in Atlas Life Sciences, now a 100% subsidiary. Atlas is a market leader in Pregabalin and has 10 products under R&D, including 6 new molecules.
Revenue contribution from the ink industry has decreased from over 90% to ~55% over the last few years, with coatings and plastics becoming key focus areas.
India now caters to more than 70% of the global phthalocyanine pigment demand, taking share from China, which previously contributed over 70%.
The Dahej unit, set up in 2020 on a 60,000 sq. mt. plot, has available capacities of 2,400 TPA for Red & Yellow Pigments, with expansion potential up to 40,000 sq. mt.
The Chattral site has commenced commercial production of API intermediates.
The Padra unit, manufacturing Phthalocyanine Pigments, is situated on a 98,000 sq. mt. plot with 25,000 sq. mt. available for further expansion.
The Odhav plant is currently running at optimum capacity utilizations for API manufacturing.
The global pigment industry is seeing a production shift from China, which is expected to put Asahi in a 'sweet spot' due to domestic manufacturing.
End-users are reevaluating their reliance on China, leading to a realignment of global supply chains, benefiting Indian manufacturers.
The three-year price erosion cycle in the API business has finally reversed, with an improvement in selling prices contributing to stronger Q4FY26 performance.
The operating environment remains challenging with global disruptions and unstable and higher raw material prices.
Elevated raw material and KSM prices, driven by geopolitical tensions, weighed on input costs for the API business.
The company faces ongoing challenges in the raw material supply chain.
Chinese competition continues to add pressure on margins in the API business.
Ongoing geopolitical volatility and global disruptions can lead to unstable and higher raw material prices, impacting profitability.
The API business faces pressure on margins due to elevated raw material costs and competition from Chinese players.
Getting approval from customers for phthalocyanine pigments is a long process, sometimes taking years, creating entry barriers.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
QoQ comparison is crucial to assess sequential momentum, especially with management noting a reversal in API price erosion and broad-based demand recovery. YoY comparison provides context for the overall business trend and the impact of geopolitical volatility on raw material prices.
Q4FY26 Revenue from Operations was ₹144.05 Cr, up 19.40% QoQ but down 5.70% YoY. FY26 Revenue from Operations was ₹535.48 Cr, down 4.78% YoY.
Q4FY26 EBITDA was ₹23.02 Cr, up 122.19% QoQ and 30.20% YoY. FY26 EBITDA was ₹56.53 Cr, down 6.12% YoY.
Q4FY26 EBITDA Margins were 15.60%, an increase of 702 bps QoQ and 407 bps YoY. FY26 EBITDA Margins were 10.43%, a decrease of 21 bps YoY.
Q4FY26 PAT was ₹10.82 Cr, up 378.05% QoQ and 57.46% YoY. FY26 PAT was ₹17.78 Cr, up 5.48% YoY.
Management aims to apply for accreditations like CEP by the end of the current financial year to grow the export business for APIs.
The company plans to invest in R&D to improve production processes, enhance yields & efficiency, and introduce new products based on market demand.
Management intends to upgrade manufacturing standards at Odhav to bottleneck capacity utilization and increase Chattral plant utilization by introducing new products.
The company is transitioning from a single-product manufacturer to one with a diversified product portfolio, continuing to improve yields and efficiency for APIs and intermediates.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| API Business Contribution to Profitability | Achieved EBITDA positivity and cash break-even for the full year. | Meaningful contribution to overall profitability at a consolidated level over the coming years. |
| CEP Certification for API Exports | Making meaningful progress towards achieving CEP certification. | Achievement by the end of the current financial year to support volume growth and access more profitable segments. |
| Azo Business Contribution to Profitability | Achieved EBITDA positivity and cash break-even for the full year. | Meaningful contribution to overall profitability at a consolidated level over the coming years. |
| Phthalocyanine Pigment Demand Environment | Saw stronger demand and broad-based demand recovery in Q4FY26. | Sustained improvement in the broader demand environment to accelerate volume growth. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 66th percentile of the scored universe and 64th percentile within Industrials. Main check: results consistency is weak at 36/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 64th pctile, median 68 · Small: 69th pctile, median 66
51 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse